Basic Information
| LncRNA/CircRNA Name | LINC01194 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | colorectal cancer |
| ICD-0-3 | C19.9 |
| Methods | qPCR, Western blot |
| Sample | colorectal cancer cell lines (HT29, HCT116,SW620) |
| Expression Pattern | up-regulated |
| Function Description | Cancer metastasis is closely related to cancer progression.In the first half of the investigation, Linc01194 was upregulated in late-stage colorectal carcinoma. |
| Pubmed ID | 30962722 |
| Year | 2019 |
| Title | Linc01194 acts as an oncogene in colorectal carcinoma and is associated with poor survival outcome. |
External Links
| Links for LINC01194 | GenBank HGNC NONCODE |
| Links for colorectal cancer | OMIM COSMIC |